2-{[6-(4-bromophenyl)-3-cyano-4-(trifluoromethyl)pyridin-2-yl]sulfanyl}-N,N-diethylacetamide

Catalog No. :
ACMECS369
CAS No. :
625377-91-5
Molecular Formula :
C19H17BrF3N3OS
Molecular Weight :
472.33

IUPAC Name:2-((6-(4-bromophenyl)-3-cyano-4-(trifluoromethyl)pyridin-2-yl)thio)-N,N-diethylacetamide

2-{[6-(4-bromophenyl)-3-cyano-4-(trifluoromethyl)pyridin-2-yl]sulfanyl}-N,N-diethylacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-{[6-(4-bromophenyl)-3-cyano-4-(trifluoromethyl)pyridin-2-yl]sulfanyl}-N,N-diethylacetamide
IUPAC Name2-((6-(4-bromophenyl)-3-cyano-4-(trifluoromethyl)pyridin-2-yl)thio)-N,N-diethylacetamide
MDL No.MFCD03697895
Molecular FormulaC19H17BrF3N3OS
Molecular Weight472.33
SMILESO=C(N(CC)CC)CSC1=NC(C2=CC=C(Br)C=C2)=CC(C(F)(F)F)=C1C#N
InChI KeyOQFGQCKBSWPRKZ-UHFFFAOYSA-N
SynonymAcetamide, 2-[[6-(4-bromophenyl)-3-cyano-4-(trifluoromethyl)-2-pyridinyl]thio]-N,N-diethyl-
CAS No.625377-91-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMECS369 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMECS369 route product structure diagram
    ACMECS369625377-91-5
Inquiry

2. ACMECS369 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMECS369 route product structure diagram
    ACMECS369625377-91-5
Inquiry

Comments (0)